These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 411760

  • 1. Tyrosinase activity in the sera of patients with malignant melanoma: method and specificity.
    Nishioka K, Romsdahl MM, Fritsche HA, McMurtrey MJ.
    Int J Cancer; 1977 Nov 15; 20(5):689-93. PubMed ID: 411760
    [Abstract] [Full Text] [Related]

  • 2. Tyrosinase activity in serum from patients with malignant melanoma.
    Agrup P, Carstam R, Wittbjer A, Rorsman H, Rosengren E.
    Acta Derm Venereol; 1989 Nov 15; 69(2):120-4. PubMed ID: 2564228
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dopa oxidase activity and ceruloplasmin in the sera of hamsters with melanoma.
    Vachtenheim J, Pavel S, Duchon J.
    Neoplasma; 1981 Nov 15; 28(1):59-65. PubMed ID: 6792550
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tyrosinase activity in primary cell culture of amelanotic melanoma cells.
    Słomiński A, Scisłowski PW, Bomirski A.
    Biosci Rep; 1983 Nov 15; 3(11):1027-34. PubMed ID: 6140964
    [Abstract] [Full Text] [Related]

  • 11. Cellular localization of tyrosinase in human malignant melanoma cell lines.
    Foa C, Aubert C.
    J Invest Dermatol; 1977 Jun 15; 68(6):369-78. PubMed ID: 405430
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tyrosinase activity in the serum of patients with malignant melanoma.
    Sonesson B, Eide S, Ringborg U, Rorsman H, Rosengren E.
    Melanoma Res; 1995 Apr 15; 5(2):113-6. PubMed ID: 7620338
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bleomycin enhances the tyrosinase activity of human malignant melanoma cells in culture.
    Bernd A, Altmeyer P, Schäfer G, Marsch WC, Holzmann H.
    Pharmacol Res Commun; 1986 Nov 15; 18(11):1075-91. PubMed ID: 2432621
    [Abstract] [Full Text] [Related]

  • 17. Serum tyrosinase in malignant disease.
    Chen YM, Chavin W.
    Oncology; 1975 Nov 15; 31(3-4):147-52. PubMed ID: 812033
    [No Abstract] [Full Text] [Related]

  • 18. Tyrosinase activity and abundance in Cloudman melanoma cells.
    Halaban R, Pomerantz SH, Marshall S, Lerner AB.
    Arch Biochem Biophys; 1984 Apr 15; 230(1):383-7. PubMed ID: 6201140
    [Abstract] [Full Text] [Related]

  • 19. Conversion of particulate tyrosinase to soluble form and to desialylated tyrosinase in human malignant melanoma.
    Nishioka K.
    FEBS Lett; 1977 Aug 01; 80(1):225-8. PubMed ID: 408193
    [No Abstract] [Full Text] [Related]

  • 20. Effect of triamcinolone acetonide on tyrosinase activity in a human melanoma cell line.
    DiSorbo DM, Harris NA, Nathanson L.
    Cancer Res; 1984 May 01; 44(5):1752-5. PubMed ID: 6424929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.